Literature DB >> 21394665

Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren's syndrome following immunosuppressive therapy.

Taio Naniwa1, Yutaka Takeda.   

Abstract

The patient described here is a 21-year-old Japanese woman with primary Sjögren's syndrome (pSS) presenting with worsening of dyspnea, palpitation, recurrent parotitis, and arthritis. Chest computed tomography showed diffuse interlobular septal thickening and ground-glass opacities. Right heart catheterization demonstrated pulmonary hypertension, right-sided heart failure, normal pulmonary capillary wedge pressure, and no evidence of arterio-venous shunt. Transbronchial lung biopsy showed luminal obliteration of pulmonary venules by intimal cellular proliferations, without abnormalities in the small pulmonary arteries. These findings were consistent with pulmonary veno-occlusive disease (PVOD). Immunosuppressive therapy, starting with prednisolone 20 mg/day and subsequently combined with azathioprine, resulted in the disappearance of the signs and symptoms, including exertional dyspnea and abnormal pulmonary parenchymal shadows on computed tomography, and the normalization of pulmonary artery pressure. So far, there have been no reported cases of PVOD associated with pSS. Of interest, immunosuppressive therapy without vasodilator therapy almost completely resolved the pulmonary hypertension in this patient.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394665     DOI: 10.1007/s10165-011-0440-9

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  4 in total

Review 1.  Pulmonary veno-occlusive disease: a misnomer?

Authors:  Cindy R Miller
Journal:  Pediatr Radiol       Date:  2012-02-05

Review 2.  Cardiovascular Disease in Primary Sjögren's Syndrome: Raising Clinicians' Awareness.

Authors:  Mihnea Casian; Ciprian Jurcut; Alina Dima; Ancuta Mihai; Silviu Stanciu; Ruxandra Jurcut
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

3.  Upfront triple combination therapy-induced pulmonary edema in a case of pulmonary arterial hypertension associated with Sjogren's syndrome.

Authors:  Kimikazu Takeuchi; Kazuhiko Nakayama; Mitsumasa Okano; Naoki Tamada; Hideya Suehiro; Yuto Shinkura; Kenichi Yanaka; Hiroyuki Onishi; Hidekazu Tanaka; Toshiro Shinke; Noriaki Emoto; Ken-Ichi Hirata
Journal:  Respir Med Case Rep       Date:  2017-12-07

4.  Progression of pulmonary veno-occlusive disease without pulmonary hypertension.

Authors:  Sarah Beshay; Marc Humbert; Roberto Barrios; Sandeep Sahay
Journal:  Pulm Circ       Date:  2022-02-21       Impact factor: 2.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.